Published Date：Mar.2021
Industry：Pharma & Healthcare
Pages：105 Table Number：127
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Ketamine market in this environment. In terms of revenue, this research report indicated that the global Ketamine market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Ketamine industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Pfizer aims at producing XX K Units Ketamine in 2020, with XX % production to take place in global market, Taj Pharmaceuticals accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Ketamine Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Ketamine Market? Pfizer Taj Pharmaceuticals Arevipharma SEQENS ... Major Type of Ketamine Covered in XYZResearch report: Injection Others Application Segments Covered in XYZResearch Market Anesthesia Pain Depression Seizures For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Ketamine Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Injection -Product Introduction and Major Manufacturers 1.1.2 Others -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Ketamine Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China Ketamine Market 3.1.1 Top Companies leading Ketamine Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China Ketamine Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU Ketamine Market 3.2.1 Top Companies leading Ketamine Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU Ketamine Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA Ketamine Market 3.3.1 Top Companies leading Ketamine Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA Ketamine Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan Ketamine Market 3.4.1 Top Companies leading Ketamine Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan Ketamine Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India Ketamine Market 3.5.1 Top Companies leading Ketamine Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India Ketamine Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia Ketamine Market 3.6.1 Top Companies leading Ketamine Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia Ketamine Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America Ketamine Market 3.7.1 Top Companies leading Ketamine Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America Ketamine Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 Ketamine Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Ketamine Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global Ketamine Sales and Growth Rate (2021-2027) 5.2 Global Ketamine Sales Value and Growth Rate (2021-2027) 6 Ketamine Competitive Analysis 6.1 Pfizer 6.1.1 Pfizer Company Profiles 6.1.2 Pfizer Product Introduction 6.1.3 Pfizer Ketamine Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 Taj Pharmaceuticals 6.2.1 Taj Pharmaceuticals Company Profiles 6.2.2 Taj Pharmaceuticals Product Introduction 6.2.3 Taj Pharmaceuticals Ketamine Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 Arevipharma 6.3.1 Arevipharma Company Profiles 6.3.2 Arevipharma Product Introduction 6.3.3 Arevipharma Ketamine Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 6.4 SEQENS 6.4.1 SEQENS Company Profiles 6.4.2 SEQENS Product Introduction 6.4.3 SEQENS Ketamine Production, Revenue (2016-2021) 6.4.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global Ketamine Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global Ketamine Sales (K Unit) by Type (2026-2027) Figure Global Ketamine Sales (K Unit) and Growth Rate (2026-2027) Figure Global Ketamine Sales Market Share (%) by Type (2019 -2020) Table Global Ketamine Sales Value (Million USD) by Type (2026-2027) Figure Global Ketamine Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global Ketamine Sales Value Market Share (%) by Type (2019-2020) Table Global Ketamine Sales (K Unit) by Application (2026-2027) Table China Ketamine Sales (K Unit) of Major Company (2016-2021) Table China Ketamine Sales Market Share of Major Company (2016-2021) Table China Ketamine Sales Value (Million USD) of Major Company (2016-2021) Figure China Ketamine Sales Value (Million USD) and Growth Rate (2016-2021) Table China Ketamine Sales Value Share of Major Company (2016-2021) Table China Ketamine Price (USD/Unit), by Type (2019-2020) Table China Ketamine Sales (Unit) by Type (2026-2027) Figure China Ketamine Sales (Unit) by Type (2026-2027) Table EU Ketamine Sales (K Unit) of Major Company (2016-2021) Table EU Ketamine Sales Market Share of Major Company (2016-2021) Table EU Ketamine Sales Value (Million USD) of Major Company (2016-2021) Figure EU Ketamine Sales Value (Million USD) and Growth Rate (2016-2021) Table EU Ketamine Sales Value Share of Major Company (2016-2021) Table EU Ketamine Price (USD/Unit), by Type (2019-2020) Table EU Ketamine Sales (Unit) by Type (2026-2027) Figure EU Ketamine Sales (Unit) by Type (2026-2027) Table USA Ketamine Sales (K Unit) of Major Company (2016-2021) Table USA Ketamine Sales Market Share of Major Company (2016-2021) Table USA Ketamine Sales Value (Million USD) of Major Company (2016-2021) Figure USA Ketamine Sales Value (Million USD) and Growth Rate (2016-2021) Table USA Ketamine Sales Value Share of Major Company (2016-2021) Table USA Ketamine Price (USD/Unit), by Type (2019-2020) Table USA Ketamine Sales (Unit) by Type (2026-2027) Figure USA Ketamine Sales (Unit) by Type (2026-2027) Table Japan Ketamine Sales (K Unit) of Major Company (2016-2021) Table Japan Ketamine Sales Market Share of Major Company (2016-2021) Table Japan Ketamine Sales Value (Million USD) of Major Company (2016-2021) Figure Japan Ketamine Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan Ketamine Sales Value Share of Major Company (2016-2021) Table Japan Ketamine Price (USD/Unit), by Type (2019-2020) Table Japan Ketamine Sales (Unit) by Type (2026-2027) Figure Japan Ketamine Sales (Unit) by Type (2026-2027) Table India Ketamine Sales (K Unit) of Major Company (2016-2021) Table India Ketamine Sales Market Share of Major Company (2016-2021) Table India Ketamine Sales Value (Million USD) of Major Company (2016-2021) Figure India Ketamine Sales Value (Million USD) and Growth Rate (2016-2021) Table India Ketamine Sales Value Share of Major Company (2016-2021) Table India Ketamine Price (USD/Unit), by Type (2019-2020) Table India Ketamine Sales (Unit) by Type (2026-2027) Figure India Ketamine Sales (Unit) by Type (2026-2027) Table Southeast Asia Ketamine Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia Ketamine Sales Market Share of Major Company (2016-2021) Table Southeast Asia Ketamine Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia Ketamine Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia Ketamine Sales Value Share of Major Company (2016-2021) Table Southeast Asia Ketamine Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Ketamine Sales (Unit) by Type (2026-2027) Figure Southeast Asia Ketamine Sales (Unit) by Type (2026-2027) Table South America Ketamine Sales (K Unit) of Major Company (2016-2021) Table South America Ketamine Sales Market Share of Major Company (2016-2021) Table South America Ketamine Sales Value (Million USD) of Major Company (2016-2021) Figure South America Ketamine Sales Value (Million USD) and Growth Rate (2016-2021) Table South America Ketamine Sales Value Share of Major Company (2016-2021) Table South America Ketamine Price (USD/Unit), by Type (2019-2020) Table South America Ketamine Sales (Unit) by Type (2026-2027) Figure South America Ketamine Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of Ketamine Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Ketamine Figure Cost Structure of Ketamine in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global Ketamine Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global Ketamine Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table Pfizer Profiles Table Pfizer Ketamine Product Introduction Table Pfizer Ketamine Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Pfizer SWOT Analysis Table Taj Pharmaceuticals Profiles Table Taj Pharmaceuticals Ketamine Product Introduction Table Taj Pharmaceuticals Ketamine Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Taj Pharmaceuticals SWOT Analysis Table Arevipharma Profiles Table Arevipharma Ketamine Product Introduction Table Arevipharma Ketamine Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Arevipharma SWOT Analysis Table SEQENS Profiles Table SEQENS Ketamine Product Introduction Table SEQENS Ketamine Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
